Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine

Curr Opin Pharmacol. 2008 Aug;8(4):359-62. doi: 10.1016/j.coph.2008.07.007. Epub 2008 Aug 21.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • Oncogene Proteins v-abl / drug effects
  • Oncogenes
  • Receptor, ErbB-2 / drug effects

Substances

  • Antineoplastic Agents
  • Oncogene Proteins v-abl
  • ERBB2 protein, human
  • Receptor, ErbB-2